Author

Martin Oaks

Unknown affiliation - Cited by 1,369

Biography

Martin oaks has done researched on transplant. he is in the department of laboratory research,usa. he has specialities in oncology, cancer researching, hematology.  Transplant Research Laboratory, Aurora St. Luke’s Medical Center, Milwaukee, WI, USA 
Title
Cited by
Year
A native soluble form of CTLA-4
MK Oaks, KM Hallett, RT Penwell, EC Stauber, SJ Warren, AJ TectorCellular immunology 201 (2), 144-153, 2000200
321
2000
Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease
MK Oaks, KM HallettThe Journal of Immunology 164 (10), 5015-5018, 2000200
291
2000
Association of the CTLA-4 gene with rheumatoid arthritis in Chinese Han population
C Lei, Z Dongqing, S Yeqing, MK Oaks, C Lishan, J Jianzhong, Q Jie, ...European journal of human genetics 13 (7), 823-828, 2005200
131
2005
Adrenocortical responses to ACTH in neonatal rats: effect of hypoxia from birth on corticosterone, StAR, and PBR
H Raff, JJ Hong, MK Oaks, EP WidmaierAmerican Journal of Physiology-Regulatory, Integrative and Comparative …, 2003200
58
2003
Hypoxia in vivo inhibits aldosterone synthesis and aldosterone synthase mRNA in rats
H Raff, BM Jankowski, WC Engeland, MK OaksJournal of applied physiology 81 (2), 604-610, 1996199
50
1996
Differential inhibition of autoreactive memory-and alloreactive naive T cell responses by soluble cytotoxic T lymphocyte antigen 4 (sCTLA4), CTLA4Ig and LEA29Y
VAL Huurman, WWJ Unger, BPC Koeleman, MK Oaks, AK Chandraker, ...Clinical & Experimental Immunology 150 (3), 487-493, 2007200
42
2007
37
1995
Vaccination in multiple myeloma: review of current literature
A Alemu, JO Richards, MK Oaks, MA ThompsonClinical Lymphoma Myeloma and Leukemia 16 (9), 495-502, 2016201
34
2016
Practical value of identifying antibodies to cryptic HLA epitopes in cardiac transplantation
M Oaks, K Michel, NZ Sulemanjee, V Thohan, FX DowneyThe Journal of Heart and Lung Transplantation 33 (7), 713-720, 2014201
28
2014
CTLA-4 is important in maintaining long-term survival of cardiac allografts
A Chandraker, V Huurman, K Hallett, X Yuan, AJ Tector, CH Park, E Lu, ...Transplantation 79 (8), 897-903, 2005200
25
2005
Lack of association between sCTLA-4 levels in human plasma and common CTLA-4 polymorphisms
A Berry, M Tector, MK OaksJournal of negative results in biomedicine 7 (1), 1-4, 2008200
22
2008
Flow cytometry assessment of residual melanoma cells in tumor‐infiltrating lymphocyte cultures
JO Richards, J Treisman, N Garlie, JP Hanson, MK OaksCytometry Part A 81 (5), 374-381, 2012201
18
2012
Ex vivo generation of genetically modified dendritic cells for immunotherapy: implications of lymphocyte contamination
N Chinnasamy, JS Treisman, MK Oaks, JP Hanson, D ChinnasamyGene therapy 12 (3), 259-271, 2005200
16
2005
15
2018
Biochemical analysis of CTLA-4 immunoreactive material from human blood
M Tector, BO Khatri, K Kozinski, K Dennert, MK OaksBMC immunology 10, 1-9, 2009200
14
2009
Many de novo donor‐specific antibodies recognize β2‐microglobulin‐free, but not intact HLA heterodimers
K Michel, R Santella, J Steers, A Sahajpal, FX Downey, V Thohan, ...Hla 87 (5), 356-366, 2016201
14
2016
Alloimmune induction of endothelial cell-derived interferon-γ–inducible chemokines1
R Raju, A Malloy, T Shah, R Smith, M Oaks, JD HosenpudTransplantation 75 (7), 1072-1074, 2003200
12
2003